4.9225
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Agenus Inc Borsa (AGEN) Ultime notizie
# Agenus and Noetik partner to develop AI-powered cancer treatment biomarkers - Investing.com India
Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock - MSN
Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo - MarketScreener
Agenus (AGEN) and Noetik Collaborate to Enhance Cancer Treatment - GuruFocus
Agenus, Noetik Enter Research Collaboration - Nasdaq
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology | AGEN Stock News - GuruFocus
AI Breakthrough: Agenus and Noetik Join Forces to Revolutionize Cancer Patient Selection Using Virtual Cell Models - Stock Titan
10 Most Undervalued Stocks to Buy for Under $5 - Insider Monkey
Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN
Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire Inc.
Is Zydus’s Agenus Deal Opportunistic Or Strategic? - insights.citeline.com
Agenus Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN
Agenus Announces Virtual Annual Shareholders Meeting - New Castle News
How to Join Agenus 2025 Virtual Shareholders Meeting: Complete Registration Guide - Stock Titan
Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN
Agenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of “Hold” from Analysts - Defense World
Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN
Research Analysts Issue Forecasts for Agenus FY2027 Earnings - Defense World
HC Wainwright Forecasts Agenus’ Q3 Earnings (NASDAQ:AGEN) - Defense World
Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million - Medical Dialogues
Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International
Agenus (NASDAQ:AGEN) Upgraded to “Buy” at HC Wainwright - Defense World
Agenus (NASDAQ:AGEN) Price Target Raised to $6.00 at Robert W. Baird - Defense World
Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL - Medical Dialogues
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - 뉴스와이어
Agenus Announces Strategic Collaboration with Zydus - TipRanks
Agenus IncSigns Partnership Agreements With Zydus Lifesciences - MarketScreener
Analyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangAgenus (NASDAQ:AGEN) - Benzinga
Agenus Shares Rise After Upgrade From HC Wainwright - marketscreener.com
H.C. Wainwright upgrades Agenus stock on strategic collaboration - Investing.com Australia
H.C. Wainwright upgrades Agenus stock on strategic collaboration By Investing.com - Investing.com South Africa
Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade - Yahoo Finance
Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Mai - GuruFocus
Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Maintained | AGEN Stock News - GuruFocus
Agenus (AGEN) Upgraded to 'Buy' by HC Wainwright & Co. | AGEN St - GuruFocus
HC Wainwright & Co. Upgrades Agenus (AGEN) - Nasdaq
Agenus (AGEN) Stock Price Target Increased by Baird | AGEN Stock News - GuruFocus
Agenus and Zydus sign agreements for botensilimab and balstilimab - Yahoo Finance
Zydus gets rights for next gen I-O platforms from Agenus - The Pharma Letter
HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target - marketscreener.com
Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | A - GuruFocus
Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | AGEN Stock News - GuruFocus
Zydus signs deal with Agenus for next-gen cancer immunotherapies - Healthcare Radius
Zydus to enter global biologics CDMO business to accelerate development of innovative therapies - Pharmabiz.com
Jane Street Group LLC Raises Stock Position in Agenus Inc. (NASDAQ:AGEN) - Defense World
Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilitiesto accelerate development of innovative therapies - APN News
Zydus to acquire Agenus’ US manufacturing facilities, forays into global biologics CDMO business - Indian Pharma Post
Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market - Express Pharma
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - StreetInsider
Agenus inks $141M deal with Zydus for cancer drugs, facilities By Investing.com - Investing.com South Africa
Zydus acquires Agenus biologics facilities for CDMO expansion By Investing.com - Investing.com South Africa
Zydus Lifesciences to acquire Agenus’s two biologics units for USD 125M - Medical Buyer
With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business - financialexpress.com
Zydus Lifesciences Subsidiary Zynext to Acquire 5.9% Stake in Agenus for $16 Million - India Infoline
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):